Adjuvant imatinib (IM) for patients (pts) with primary gastrointestinal stromal tumor (GIST) at significant risk of recurrence: PERSIST-5 planned 3-year interim analysis Meeting Abstract


Authors: Raut, C. P.; Espat, N. J.; Maki, R. G.; Araujo, D. M.; Keir, C. H.; Williams, T. F.; DeMatteo, R. P.
Abstract Title: Adjuvant imatinib (IM) for patients (pts) with primary gastrointestinal stromal tumor (GIST) at significant risk of recurrence: PERSIST-5 planned 3-year interim analysis
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036900174
PROVIDER: wos
DOI: 10.1200/JCO.2015.33.15_suppl.10537
Notes: Meeting Abstract: 10537 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ronald P DeMatteo
    637 DeMatteo